Average Co-Inventor Count = 8.83
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (17 from 3,685 patents)
2. Bristol Meyers Squibb Company (1 from 41 patents)
3. Syngene International Limited (1 from 7 patents)
17 patents:
1. 12275721 - Indazole carboxamides as kinase inhibitors
2. 12172975 - 1H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RIPK1)
3. 12157733 - Aminotriazolopyridines as kinase inhibitors
4. 12110290 - Triazolopyridinyl compounds as kinase inhibitors
5. 12084426 - Indazole carboxamides as kinase inhibitors
6. 11767322 - Triazolopyridinyl compounds as kinase inhibitors
7. 11618753 - Aminopyrrolotriazines as kinase inhibitors
8. 11440913 - Aminoimidazopyridazines as kinase inhibitors
9. 10913738 - Aminotriazolopyridines as kinase inhibitors
10. 10301306 - Substituted dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-ones as RIPK3 inhibitors
11. 9765018 - IDO inhibitors
12. 9675571 - Inhibitors of indoleamine 2,3-dioxygenase (IDO)
13. 9556178 - Imidazotriazinecarbonitriles useful as kinase inhibitors
14. 9273057 - Imidazotriazinecarbonitriles useful as kinase inhibitors
15. 8940736 - Imidazotriazinecarbonitriles useful as kinase inhibitors